FDA Warning Letter Recipients Become Basis for State Lawsuits
According to The Legal Times, state attorneys general are looking closely at the Food and Drug Administration’s (FDA) warning…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
NEW
Physician Payment Sunshine: GSK Expands to Research and Global Transparency
GlaxoSmithKline (GSK) announced that starting in 2010, they will be disclosing payments to researchers, in addition to payments…
State Policy: Iowa Senate Passes Payment “Gift” Ban and Registry, Data…
In a largely partisan vote the Iowa State Senate passed (30-18) Senate Bill 389, a comprehensive healthcare reform bill which…
US Drug Prescription Drug Sales Growth Comes to a Screeching Halt
According to IMS Health, the growth rate for prescription drugs slowed to 1.3 percent in 2008, to $291 billion. …
Minnesota Data Mining Restrictions Advance
Minnesota was once well known for its home town company, Minnesota Mining and Manufacturing (3M), which grew into one of the…
FDA: Don’t Leak This……Don’t Leak This
Do do do do….do do do do don’t leak this… this may sound like a line from the MC Hammer 1990 music hit U Can’t Touch This. …
JAMA Editor: Calls Critic “A Nobody and a Nothing”
Remember how in high school, we would put each other down, and make rude comments about each other. As we got older, we…
Conflict of Interest: Why Research and Government Need the Private Sector
This weekend, there are two major editorials providing an alternate perspective on research and conflict of interest. The…
Health Care Reform: Obama Announces Key FDA Appointments: Hamburg and…
In his weekly address, President Barack Obama announced the appointments of Dr. Margaret Hamburg as Commissioner of the…
Medical Journals: Hierarchy of Purity
This week in Burrells Reports Peter Pitts executive director of the Center for Medicine in the Public Interest and Public…